Tareq Abadl: Low Platelets, But the Marrow Is Fighting Back? – Think about IPF
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
“Low platelets… but the marrow is fighting back?
Think: Immature Platelet Fraction (IPF)
In hematology, the Immature Platelet Fraction (IPF) measures the percentage of newly released, RNA-rich platelets circulating in the blood.
These young platelets are the platelet equivalent of reticulocytes in anemia — giving us a real-time glimpse into marrow platelet production.
Why is IPF important?
Thrombocytopenia generally happens through two major mechanisms:
- Decreased platelet production: Bone marrow is not producing enough platelets.
- Increased platelet destruction or consumption: Platelets are being destroyed, consumed, or lost faster than normal.
This is where IPF becomes clinically useful:
High IPF suggests active marrow response and increased platelet production.
Often seen in:
- Immune thrombocytopenia (ITP)
- Peripheral platelet destruction
- Consumptive processes
- Recovery after marrow suppression or chemotherapy
Low or normal IPF may suggest impaired marrow production
Such as:
- Aplastic anemia
- Marrow infiltration
- Chemotherapy-related suppression
In practice, IPF helps answer an important clinical question:
- Is the marrow failing to produce platelets… or
- Is the body destroying and consuming them peripherally?
But IPF should never be interpreted alone.
A proper thrombocytopenia workup still begins with:
- CBC
- Peripheral smear review
- Excluding pseudothrombocytopenia from platelet clumping.”

Other posts featuring Tareq Abadl on Hemostasis Today.
-
Aug 22, 2026, 17:27Masudah Paleker: Suboptimal Warfarin Control in South Africa
-
Aug 22, 2026, 17:26Maxime Dely: Sickle Cell Disease – Behind Every Exchange, There Is a Donor
-
Aug 22, 2026, 17:05Mostafa Elshazly: Managing Anticoagulant-Related Bleeding in Clinical Practice
-
Aug 22, 2026, 17:01Cesarovic Nikola: FDA Data Reanalysis Raises Questions About Moderna’s mFLUSIVA Risk-Benefit Profile
-
Aug 22, 2026, 16:38Andreas Linkermann: Decoding the Chain Reaction of Ferroptotic Cell Death
-
Aug 22, 2026, 16:33Nicolas Hulscher: FDA Data Reanalysis Raises Alarms Over Moderna’s MFLUSIVA
-
Aug 22, 2026, 16:19Moti Haim: Transforming AF Care in the Elderly
-
Aug 22, 2026, 16:12Hussam Hammoud: A Slap Is Not “Just a Slap” When the Patient Has Hemophilia
-
Aug 22, 2026, 15:53Howard Smith: Publix’s GreenWise Organic Frozen Berries Have E. coli Contamination